178 related articles for article (PubMed ID: 22836146)
21. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
22. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
[TBL] [Abstract][Full Text] [Related]
23. Excess amounts of 3-iodo-l-tyrosine induce Parkinson-like features in experimental approaches of Parkinsonism.
Fernández-Espejo E; Bis-Humbert C
Neurotoxicology; 2018 Jul; 67():178-189. PubMed ID: 29885340
[TBL] [Abstract][Full Text] [Related]
24. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice.
Paul R; Dutta A; Phukan BC; Mazumder MK; Justin-Thenmozhi A; Manivasagam T; Bhattacharya P; Borah A
Neuroscience; 2018 Sep; 388():347-356. PubMed ID: 30075243
[TBL] [Abstract][Full Text] [Related]
26. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
27. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
28. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
29. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Fletcher EJR; Moon LDF; Duty S
BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
[TBL] [Abstract][Full Text] [Related]
30. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
31. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
32. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
33. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.
Ugrumov MV; Khaindrava VG; Kozina EA; Kucheryanu VG; Bocharov EV; Kryzhanovsky GN; Kudrin VS; Narkevich VB; Klodt PM; Rayevsky KS; Pronina TS
Neuroscience; 2011 May; 181():175-88. PubMed ID: 21382448
[TBL] [Abstract][Full Text] [Related]
34. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
35. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
36. Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.
Baiguera C; Alghisi M; Pinna A; Bellucci A; De Luca MA; Frau L; Morelli M; Ingrassia R; Benarese M; Porrini V; Pellitteri M; Bertini G; Fabene PF; Sigala S; Spillantini MG; Liou HC; Spano PF; Pizzi M
Brain; 2012 Sep; 135(Pt 9):2750-65. PubMed ID: 22915735
[TBL] [Abstract][Full Text] [Related]
37. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
[TBL] [Abstract][Full Text] [Related]
38. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
[TBL] [Abstract][Full Text] [Related]
39. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
[TBL] [Abstract][Full Text] [Related]
40. Nasal application of kisspeptin-54 mitigates motor deficits by reducing nigrostriatal dopamine loss in hemiparkinsonian rats.
Sinen O; Sinen AG; Derin N; Aslan MA
Behav Brain Res; 2024 Jun; 468():115035. PubMed ID: 38703793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
